Optometrist · Houston, TX
NPI
1194721423
Since 2005
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3100 Weslayan St, Ste 400
Houston, TX, 77027
Phone (713) 526-1600
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
859 services
Medicare patients, 2024
417
Average age 75
Drug cost, 2024
$454K
1,961 prescriptions
Company payments, 2025
$1,190
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Garza was code 99213 (office e&m - established), 275 times for 172 patients. In total David A Garza billed 859 services in 21 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 275 | 172 | $57.55 | $16K |
| 92014 Ophthalmological E&M | Office | 243 | 239 | $80.07 | $19K |
| 92133 Computerized Ophthalmic Imaging | Office | 100 | 98 | $20.57 | $2,057 |
| 92083 Vision, Hearing, and Speech Services | Office | 88 | 81 | $37.12 | $3,266 |
| 99214 Office E&M - Established | Office | 53 | 47 | $85.58 | $4,536 |
| 92134 Computerized Ophthalmic Imaging | Office | 26 | 26 | $27.31 | $710 |
| 92004 Ophthalmological E&M | Office | 24 | 24 | $85.12 | $2,043 |
By year: 2022 $45K for 725 services; 2023 $55K for 881 services; 2024 $55K for 859 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A Garza prescribed most often to Medicare patients was Latanoprost, with 717 prescriptions and refills. In total David A Garza wrote 1,961 Medicare prescriptions that cost $454K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 717 | 1,866 | 234 | $11K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 206 | 523 | 78 | $4,782 |
| Lumigan Bimatoprost | 144 | 312 | 47 | $77K |
| Dorzolamide Hcl Generic | 119 | 293 | 42 | $2,291 |
| Brimonidine Tartrate Generic | 100 | 217 | 38 | $1,474 |
| Epinastine Hcl Generic | 94 | 143 | 45 | $6,827 |
| Prednisolone Acetate Generic | 58 | 68 | 49 | $2,246 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 53 | 53 | 44 | $2,324 |
| Combigan Brimonidine Tartrate/Timolol | 39 | 61 | Under 11 | $14K |
| Tyrvaya Varenicline Tartrate | 36 | 64 | Under 11 | $40K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 36 | 74 | 17 | $8,162 |
| Xdemvy Lotilaner | 26 | 38 | 19 | $46K |
| Timolol Maleate Generic | 26 | 57 | 14 | $224 |
| Simbrinza Brinzolamide/Brimonidine Tart | 24 | 51 | Under 11 | $7,725 |
| Azelastine Hcl Generic | 24 | 46 | 14 | $822 |
Brand drugs: 916 claims; generic drugs: 1,045 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Garza $1,190 ($1,190 in general payments such as food, travel and fees) from 15 companies. The largest payer was Alcon Vision LLC with $228.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 13 | $228 |
| Bausch & Lomb Americas Inc. BLCO | 11 | $181 |
| Abbvie Inc. ABBV | 7 | $136 |
| Dompe US, Inc. | 4 | $119 |
| Glaukos Corporation GKOS | 1 | $106 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $86.73 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $67.56 |
| Johnson & Johnson Vision Care, Inc. JNJ | 2 | $61.37 |
| Astellas Pharma US Inc 4503.T | 2 | $46.8 |
| Oyster Point Pharma, Inc. | 2 | $42.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.